A comprehensive system combining CTCeptor isolation technology with HyPICC staining methodology for complete circulating tumor cell analysis. The integrated system enables precise single-cell selection and multi-omics diagnostics for personalized cancer treatment strategies.
Manufactured by
Seoul, South Korea
CTCELLS is a cutting-edge cancer diagnostics and drug development company, founded on the premise that effective cancer treatment requires tailored solutions for each individual. Leveraging Circulating Tumor Cell (CTC) liquid biopsy technology, CTCELLS leads the industry with its unique automation capabilities, enabling the isolation of all types of circulating tumor cells. With a strong focus on developing innovative cancer treatments, CTCELLS is dedicated to improving patient outcomes by matching cancer characteristics with the most suitable therapies, setting its sights on bringing hope to patients facing challenging cancer types. Join us in our mission to transform the landscape of cancer treatment.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 1 relevant product
GENERAL BIOLOGICALS CORP.
Taiwan · 1 relevant product
DMB Diagnostics
Germany · 1 relevant product
8 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →2 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 12 closest product alternatives
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Diagnostic system for isolation and detection of circulating tumor cells from patient blood samples. Provides prognostic and predictive information for cancer monitoring and treatment planning.
GENERAL BIOLOGICALS CORP. · Taiwan
High-sensitivity isolation system for circulating tumor cells (CTCs) and circulating tumor microemboli (CTMs) for precision oncology and cancer monitoring. Enables early cancer detection and treatment monitoring with enhanced sensitivity.
DMB Diagnostics · Germany
An advanced liquid biopsy platform for capturing and analyzing circulating tumour cells from blood samples. Supports real-time investigation of tumour dynamics and therapeutic response in oncology research.
9 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products